AOD 9604 2mg

AOD 9604 is a C-terminal fragment of the human growth hormone (HGH), amino acids 176–191. It was originally designed for its lipolytic effect but has drawn much attention from scientists since it exerts a specific action on fat breakdown without the non-specific anabolic or diabetogenic effect of full-length growth hormone.

This peptide replicates the lipolytic action of HGH by triggering the same metabolic pathways used in lipid metabolism. AOD 9604 has no effect on blood sugar or cell growth as compared to traditional growth hormone therapies and thus is an interesting prospect for obesity and metabolic research. It has potential in research for the study of fat reduction from specific areas, even more so in the areas of fat distribution without any effect on muscle tissue or affecting insulin sensitivity.

• Targeted fat loss: Triggers lipolysis without affecting muscle growth or glucose metabolism.
• Non-anabolic profile: It lacks any of the full-length HGH’s negative side effects, i.e., it has no joint swelling or insulin resistance.
• Enables metabolic control: Facilitates fat-storing processes and aids body composition studies.
• High-purity formulation: Made under strict laboratory conditions for consistency and research-quality requirements.
• Selective action: Specifically targets adipose tissue with little action on other cell pathways.
• Extensively researched: Widely tested in preclinical and phase I/II human trials for safety and efficacy.

Store somewhere dry and cool. The recommended range of temperatures for storage is -20°C to 4°C or 4°F to 39°F.

Research shows AOD 9604 has most commonly been used in research on fat metabolism and weight loss. It’s usually examined for its potential role in triggering lipolysis and reducing adiposity and enhancing metabolic efficiency in the obese. Its local action without hormone-mediated systemic effect makes it a sought-after agent in metabolic research.